Personal Lubricants Market Size & Share 2026-2035

Personal Lubricants Market Size

The personal lubricants market is valued at USD 1.8 billion in 2025. It is forecast to rise from USD 2 billion in 2026 to approximately USD 4.6 billion by 2035, reflecting an estimated 9.7% CAGR during 2026-2035.

Personal lubricants serve two overlapping demand bases: symptom management for dryness and pain during intercourse, and discretionary sexual-wellness use. In the United States, personal lubricants are regulated as Class II medical devices under 21 CFR 884.5300, establishing a safety and substantial-equivalence framework that raises the importance of formulation quality, biocompatibility testing, and compliant product claims. ^[1] That regulatory status separates clinically positioned lubricants from conventional personal-care products and supports differentiation for suppliers able to substantiate safety and performance.

The clinical foundation of demand is substantial. Genitourinary syndrome of menopause can affect 27% to 84% of postmenopausal women, while vaginal dryness is reported by roughly 60% to 78% of affected women. ^[2] Lubricants and moisturizers are commonly used non-prescription interventions because they can be accessed without a prescription and incorporated into routine sexual-health management. Demand is also widened by postpartum hormonal changes, cancer treatment, fertility planning, and consumer interest in products designed for comfort, pleasure, or condom-compatible use.

Digital retail has altered how this category reaches consumers. Online stores account for approximately 59.4% of 2025 sales, or about USD 1,089 million, because privacy, discreet fulfillment, and broad product selection reduce purchase friction. Drug stores retain a healthcare-adjacent role, particularly for consumers seeking familiar brands or pharmacist-led guidance. Product development across water-based, silicone-based, oil-based, and hybrid formats is broadening the category beyond basic lubrication, particularly through fragrance-free, fertility-oriented, and hydration-focused products.

North America remains the largest regional market, representing 37.45% of 2025 value, or about USD 686.9 million. The United States accounts for approximately USD 617 million of this total. Asia Pacific represents 17.78% of the market, or around USD 326.1 million, and is positioned for faster expansion as digital commerce reduces the visibility barrier associated with intimate-wellness purchases.

Regulatory requirements and consumer scrutiny of ingredients make formulation capability commercially consequential. Brands can no longer rely solely on familiarity or physical shelf presence when digitally native competitors can explain ingredient choices, target specific use cases, and reach consumers discreetly. The forecast therefore depends on both penetration growth and a gradual improvement in product mix, with online channels acting as the principal route for premium and specialized formulations.

Key Drivers

Increasing prevalence of vaginal dryness and dyspareunia

Dyspareunia has been reported at a worldwide prevalence of 3% to 18%, with lifetime prevalence estimates of 10% to 28%. ^[3] Menopause increases the relevance of lubrication because estrogen decline can affect vaginal tissue, comfort, and sexual function. A systematic review found that lubricants and moisturizers were used more frequently than low-dose vaginal estrogen among women managing genitourinary syndrome of menopause symptoms. ^[4]

The commercial importance of this driver lies in accessibility. Lubricants can be purchased without a prescription, which allows consumers to address discomfort before seeking clinical treatment. In a British probability survey, 7.5% of sexually active women reported painful sex, and vaginal dryness was the factor most strongly associated with that outcome. Suppliers that connect product design to specific symptoms, rather than relying on generic pleasure claims, can reach a population whose need is ongoing but often under-discussed.

Fertility-sensitive use is a related formulation opportunity. The World Health Organization advises procurement agencies to consider osmolality, pH, and mucosal safety when selecting lubricants. This has supported demand for products positioned around lower-osmolality and sperm-compatible formulations, where clinical relevance can justify a premium over conventional gels.

Growing desire among older adults to maintain active sexual lives

Sexual activity continues across later life, creating a persistent need base for comfort-oriented products. U.S. data summarized by the American Geriatrics Society show that 85% of men and 62% of women aged 57 to 65 reported sexual activity in the preceding year; among adults aged 75 to 85, 39% of men and 17% of women remained sexually active. The same demographic groups are more likely to experience physiological changes associated with dryness and discomfort.

This demand is reinforced by population aging in developed markets. The United Kingdom's population estimates continue to show a growing older population, enlarging the cohort for whom menopause-related or age-related sexual-health needs are relevant. For lubricant manufacturers, the implication is that mature consumers should not be treated as a residual audience. Products that combine straightforward clinical framing, easy-to-understand labeling, and pharmacy or digital availability can convert a demographic with recurring use occasions.

Peptonic Medical's VagiVital Active Glide launch illustrates the more clinical version of this strategy. The product was introduced as a fragrance-free water-based lubricant using the company's ActiveGel platform, with positioning directed toward comfort and care rather than novelty alone. Such launches suggest that older-adult demand is increasingly being addressed through intimate self-care rather than through narrowly recreational messaging.

Changing attitudes toward sexual wellness and product education

The normalization of sexual wellness expands the market beyond consumers with a symptom-driven purchase reason. Brands increasingly frame lubricants as part of comfort, pleasure, and relationship wellness, helping reduce the historical association between lubricant use and sexual dysfunction. Durex Canada's May 2024 "Unlocking New Pleasures" campaign explicitly emphasized lubricants as pleasure-enhancing products.

Digital commerce amplifies this attitudinal shift because it separates product discovery from public checkout. Consumers can compare ingredients, formats, reviews, and use cases without a face-to-face retail interaction. This is particularly relevant in markets where social norms continue to discourage open discussion of sexual health but smartphone-based shopping is widespread.

More informed consumers also create demand for formulation transparency. WHO guidance on lubricant specifications has made osmolality, pH, fragrance, and mucosal compatibility more relevant selection criteria for healthcare-oriented buyers and educated consumers. As a result, ingredient disclosure is becoming both a compliance matter and a commercial tool.

Continuous product launches in developed economies

New product activity is extending lubricants from a single-purpose category into a differentiated intimate-wellness segment. BioFilm introduced ASTROGLIDE Lube Plus Libido in September 2023, combining water-based lubrication with ingredients such as ashwagandha, hemp extract, watermelon extract, and menthol. The launch demonstrates how established brands are seeking additional value through sensory or arousal-oriented benefits.

Regulatory clearance also remains a route to differentiation. Good Clean Love received FDA 510(k) clearance for Coconut Hybrid in September 2024, adding a hybrid product to its cleared lubricant portfolio. Regulatory validation can be particularly important for brands targeting consumers who associate intimate-use products with medical-device safety expectations.

Innovation is occurring alongside, rather than instead of, ingredient simplification. The World Health Organization's procurement guidance favors products without added fragrance, colorants, spermicides, or herbal ingredients in relevant condom-use settings. This creates two distinct innovation paths: minimalist formulations for sensitive users and specialized formulations designed around a clearly defined functional outcome.

Key Restraints

Lack of awareness and proper care

A clinically relevant need does not automatically translate into lubricant use. Research on genitourinary syndrome of menopause indicates that vaginal health is often not discussed during routine medical visits and that awareness of available treatment options remains low. Many symptomatic consumers consequently self-manage discomfort without a product, delay treatment, or do not connect their symptoms with a treatable condition.

The issue is compounded by cultural inhibition. In markets where sexual-health products carry social stigma, consumers may avoid pharmacy conversations and physical-store purchases even when products are available. Digital channels reduce this barrier but do not fully solve the awareness gap, because discreet access cannot substitute for reliable information on product selection, safety, and compatibility.

The market's male segment, valued at approximately USD 1,053 million in 2025, is not immune to this challenge. Male-directed products have historically been marketed around condoms or pleasure, which may limit awareness of lubricant use in broader comfort and sexual-health contexts. Category expansion therefore requires education that is useful without being overly medicalized or culturally misaligned.

Adverse effects caused by ingredient concerns

Ingredient safety is a material restraint because the product is applied to sensitive tissue. In vitro research using a three-dimensional human vaginal epithelium model found that highly hyperosmolar lubricants could reduce epithelial barrier properties. WHO guidance advises avoiding lubricants with osmolality above 1,200 mOsm/kg, pH below 5.5, or certain ingredients associated with mucosal concerns in its procurement context.

Research has also linked some common lubricant ingredients and hyperosmolar formulations with adverse effects on sperm motility or chromatin integrity, making formulation selection more consequential for consumers attempting conception. Although product performance and clinical relevance vary by formulation, the evidence raises the cost of broad, undifferentiated ingredient claims.

The vaginal microbiome introduces another layer of uncertainty. Laboratory evidence indicates that some lubricant constituents may affect Lactobacillus growth and vaginal microbial balance, although translation to real-world clinical outcomes remains less certain. Consumers may nevertheless respond to these concerns by shifting toward fragrance-free, glycerin-free, paraben-free, or otherwise minimalist products.

PFAS-related reporting has added reputational risk to the category. A 2024 investigation reported fluorine findings in some lubricants and condoms based on commissioned laboratory testing, increasing public attention to chemical exposure in intimate products. For manufacturers, this raises the importance of supplier controls, transparent testing, and cautious communication. For smaller clean-label brands, it creates an opportunity only if claims are substantiated and not used to overstate the evidence.

Formulation scrutiny is reshaping competitive advantage at the same time. Safety concerns can suppress category trust when claims are vague or ingredients are poorly understood, yet the same concerns reward brands that document compatibility, minimize unnecessary additives, and communicate appropriate use clearly. The likely result is not a uniform shift toward premium products, but a wider gap between transparent, use-case-specific formulations and undifferentiated legacy products.

Personal Lubricants Market Segment Analysis

Water-based

Water-based lubricants account for 54.91% of the market, or approximately USD 1,007 million in 2025. Their leading position reflects broad condom compatibility, easy cleanup, and flexibility for incorporating hydration-oriented or fertility-sensitive formulation features. Water-based formats can serve both value-oriented pharmacy demand and premium clinical positioning, allowing brands to differentiate through ingredient selection without requiring consumers to change their preferred base format.\

The segment is becoming more segmented internally. BioFilm's FDA-cleared ASTROGLIDE Glycerin & Paraben Free product demonstrates demand for ingredient-reduction positioning, while ASTROGLIDE Lube Plus Libido reflects the alternative strategy of adding functional benefits. The category's scale means that innovations in osmolality, hydration, or fragrance-free design are likely to be adopted first in water-based formats rather than displacing them.

Silicon-based

Silicon-based lubricants represent 28.43% of 2025 market value, or around USD 521 million. Their main advantage is performance duration: silicone formulations remain lubricious longer than many water-based products and can be preferred where reapplication frequency matters. WHO specifications identify polydimethylsiloxane content and viscosity requirements for silicone lubricants in applicable procurement settings. ^[5]

The trade-off is use-case specificity. Silicone formulations can be incompatible with silicone sex toys, limiting their utility for some consumers. This restricts mass-market substitution but preserves a premium niche for products emphasizing long-lasting feel, water resistance, and minimalist silicone-based ingredient systems.

Oil-based

Oil-based lubricants account for 11.76% of market value, or about USD 216 million in 2025. They appeal to consumers seeking longer-lasting moisturization and natural-oil positioning, particularly in massage and non-condom-use contexts. Their principal limitation is latex incompatibility: oils can weaken latex condoms and increase failure risk.

This limitation keeps the segment concentrated in specific use occasions rather than allowing it to compete directly with water-based products for general condom-compatible use. Growth is therefore likely to depend on targeted natural-wellness positioning and clear communication of compatibility restrictions.

Hybrid

Hybrid lubricants represent approximately 4.90% of the market, or roughly USD 90 million in 2025. These products typically combine water- and silicone-based elements to balance duration with easier cleanup and broader compatibility. Good Clean Love's Coconut Hybrid clearance reflects growing interest in products that bridge traditional formulation categories. ^[6]

Hybrid development carries greater technical complexity because stable formulations must maintain performance across multiple base systems. That complexity may limit smaller entrants, but it can support premium pricing for brands that deliver a distinct performance benefit rather than a superficial combination of ingredients.

Male

The male segment represents approximately 57.4% of market value, or around USD 1,053 million in 2025. Historical purchasing patterns, condom adjacency, and recreational-use positioning have supported this share. Product development in the segment includes longer-lasting textures, warming or sensory formats, and products paired with male sexual-wellness accessories.

The commercial risk is that male-oriented demand can be more exposed to discretionary spending cycles than clinical-use demand. Brands that rely exclusively on novelty positioning may face lower repeat relevance than those that build products around comfort, compatibility, and quality.

Female

The female segment accounts for approximately 42.6% of 2025 value, or about USD 781 million. Its revenue share remains below the apparent prevalence of dryness, dyspareunia, and menopause-related symptoms, indicating a conversion gap rather than a lack of underlying need. Products positioned around vaginal comfort, non-hormonal symptom management, fertility compatibility, and ingredient sensitivity have the strongest rationale for expanding penetration.

Peptonic Medical's launch of VagiVital Active Glide reflects this clinical-intimate-care direction. The most meaningful opportunity in the female segment is not simply a broader product range; it is better alignment between product information, healthcare guidance, and consumer confidence at the point of purchase.

Online stores

Online stores lead distribution with approximately 59.4% of 2025 sales, or around USD 1,089 million. Discreet delivery reduces embarrassment, while broad assortments allow brands to target narrow use cases that would not justify physical shelf space. Online environments also support subscription, replenishment, and direct communication around ingredients and product compatibility.

The concentration of sales online creates a corresponding dependency on platform economics. Marketplace visibility, reviews, advertising costs, fulfillment rules, and counterfeiting controls can materially influence a brand's ability to retain margin and consumer trust. Direct-to-consumer relationships are therefore strategically valuable, particularly for premium specialized products.

Drug stores

Drug stores hold about 26.1% of sales, or approximately USD 479 million. Their role is reinforced by the healthcare framing of lubricant purchases for consumers experiencing dryness or discomfort. Pharmacy availability can convert need into purchase for consumers who may not search for a specialized product online.

Although digital channels have reduced drug stores' relative share, pharmacies remain important where pharmacist familiarity, brand recognition, and convenient local access matter. They are especially relevant to products that position themselves as clinically suitable or symptom-oriented.

Hypermarkets and supermarkets

Hypermarkets and supermarkets account for roughly 10.0% of 2025 sales, or about USD 184 million. Mainstream retail placement can normalize the category by making it available alongside other personal-care products. However, limited shelf space generally favors leading brands and high-velocity stock-keeping units.

This channel is less effective for products requiring education, specialized compatibility advice, or nuanced ingredient positioning. It is better suited to building familiarity and trial than to carrying the full premium and clinical range available online.

Specialty stores

Specialty stores represent approximately 4.5% of sales, or around USD 82 million. Their contribution is modest in value terms but disproportionate in product discovery and consumer education. Staff-led advice can help consumers distinguish between water-based, silicone-based, oil-based, and hybrid options in ways that conventional retail cannot.

Lovehoney's September 2024 partnership with Just Eat Takeaway extended sexual-wellness delivery in the UK, Austria, and Denmark, showing how specialty retailers are testing faster fulfillment models to retain convenience advantages. This channel remains important for niche brands seeking early adopters and for premium products whose benefits are easier to explain through consultation.

Distribution is increasingly separating discovery from validation. Online channels provide privacy and assortment, while drug stores retain relevance where consumers seek a healthcare-adjacent purchase setting. The female segment represents the clearest conversion opportunity because clinical need is substantial but product use remains constrained by awareness, diagnosis, and stigma. Brands that combine clinically credible formulation with discreet digital access and clear education are better positioned than those competing only on sensory novelty.

Personal Lubricants Market Regional Analysis

North America

North America accounts for 37.45% of the market, or approximately USD 686.9 million in 2025. The United States contributes about USD 617 million, while Canada represents roughly USD 69 million. Mature e-commerce infrastructure, established brand awareness, and FDA medical-device oversight support a market where formulation claims and channel execution are both important.

United States U.S. manufacturers operate under the FDA framework for personal lubricants, which requires medical-device compliance and can support safety-led product differentiation. Hello Cake's October 2024 acquisition of Trigg Laboratories, manufacturer of the WET brand, added a 70,000-square-foot manufacturing and distribution facility and was accompanied by an USD 18 million Series B financing round. ^[7] The transaction highlights the strategic value of controlling production and private-label capability in a category that increasingly depends on rapid product iteration.

Canada Canada represents approximately 10.1% of North American value. Durex Canada's pleasure-focused campaign demonstrates that established suppliers are using consumer communication to expand lubricant use beyond symptom-oriented purchasing. The market benefits from proximity to U.S. supply and brand ecosystems while retaining room for further digital and pharmacy distribution development.

Europe

Europe represents 25.65% of the market, or around USD 470.6 million in 2025. Its established pharmacy systems, older population, and varied consumer attitudes create a stable but heterogeneous opportunity.

Germany Germany contributes approximately USD 99.5 million. Research across European populations has documented a substantial burden of vulvovaginal atrophy symptoms among postmenopausal women, supporting ongoing demand for non-prescription symptom-management products. Consumer attention to formulation quality and medical-device standards can favor premium water-based and silicone-based products.

United Kingdom The UK combines established pharmacy and specialty-retail channels. Lovehoney Group reported 2023 revenue of £101.2 million, compared with £121.8 million in 2022, illustrating pressure on discretionary sexual-wellness spending during a period of higher household costs. Clinical-use demand may be more resilient than novelty-led consumption, making portfolio balance important for suppliers.

France, Spain, and Italy These markets benefit from strong pharmacy cultures that can provide socially acceptable purchase routes for symptom-oriented users. European symptom-prevalence evidence indicates that substantial demand remains untreated, particularly where consumers are reluctant to discuss intimate health.

Netherlands Progressive attitudes toward sexual health and broad consumer awareness support relatively favorable category penetration. The country remains a useful market for premium and specialty formulations despite its smaller absolute scale.

Asia Pacific

Asia Pacific accounts for 17.78% of 2025 market value, or approximately USD 326.1 million, and is expected to be the fastest-growing regional market.

China China represents approximately USD 72.7 million. A multicenter study of adults aged 50 years and older found that 46.8% of men and 40.7% of women remained sexually active, with lubrication difficulties included among reported sexual-response concerns. ^[8] Mobile commerce is critical because it enables private purchase in a market where physical-store buying can remain sensitive.

Japan Japan's advanced aging profile and consumer preference for high-quality personal-care products support demand for clinically positioned and minimalist formulations. Pharmacy and specialty channels can both play a role in product access.

India India offers a large long-term consumer base and rapidly expanding mobile commerce, but category penetration remains restricted by stigma, uneven sex education, and limited formal sexual-wellness retail. Domestic suppliers and online-first brands may have an advantage where they can combine local distribution with culturally appropriate communication.

Australia Australia's mature digital retail environment and alignment with U.S. and UK consumer-health trends support adoption of premium and specialty formats.

South Korea High digital engagement and strong personal-care purchasing culture make South Korea receptive to transparent, design-led intimate-wellness products, particularly those that fit established e-commerce behaviors.

Latin America

Latin America accounts for 11.59% of global value, or approximately USD 212.6 million in 2025.

Brazil Brazil contributes about USD 69.7 million. ANVISA's framework for personal-hygiene products establishes notification, labeling, and microbiological-control requirements that manufacturers must navigate before commercialization. The combination of a large consumer population and expanding online retail supports growth, but compliance requirements can raise entry costs for smaller international brands.

Mexico Mexico benefits from proximity to U.S. brands, established pharmacy networks, and rising urban e-commerce use. Market development depends on whether digital privacy and product education can overcome persistent cultural barriers.

Argentina Argentina's urban consumer base supports category demand, while inflation and currency volatility can constrain affordability for premium imported formulations. Localized price architecture is therefore important for maintaining access.

Middle East and Africa

Middle East and Africa represents approximately 7.33% of 2025 market value, or about USD 134.4 million.

South Africa South Africa has relatively developed pharmacy and retail infrastructure compared with many sub-Saharan markets. Healthcare-related awareness of lubricant compatibility with barrier methods can provide a more credible route to category education than recreational positioning alone.

Saudi Arabia Saudi Arabia contributes approximately USD 34.1 million. E-commerce is central to access because discreet purchasing remains important, while clinically framed products may be more readily accepted than overtly pleasure-led offerings.

UAE The UAE's expatriate consumer base, high incomes, and developed pharmacy and online retail ecosystems support higher per-capita demand than many regional peers. Premium products can perform well when they combine safety-oriented messaging with convenience.

Asia Pacific presents the strongest expansion case because low current penetration coincides with large consumer populations and sophisticated mobile-commerce ecosystems. Yet digital access does not remove the need for culturally credible education. China can scale through mobile commerce and brand familiarity, while India's opportunity is larger but likely to develop more gradually because awareness and retail formalization remain uneven. Latin America and Middle East and Africa offer selective growth opportunities where suppliers can align privacy, affordability, regulatory compliance, and healthcare-oriented messaging.

Personal Lubricants Market Share & Competitive Landscape

The market is moderately fragmented. Large consumer-health companies hold advantages in pharmacy access, condom-brand adjacency, and advertising scale, while specialist companies compete through ingredient transparency, medical-device clearances, fertility positioning, and focused digital distribution.

Aculife Healthcare participates in the Indian market, where domestic supply, pharmacy availability, and online access are important to overcoming uneven category penetration.

BioFilm manufactures the ASTROGLIDE brand. Combe announced its acquisition of BioFilm in May 2023, integrating ASTROGLIDE with its intimate-health portfolio. ^[9] BioFilm's Lube Plus Libido launch shows the company's effort to extend the brand beyond basic lubrication.

Church & Dwight competes through Trojan, using condom-brand recognition and mass-market distribution to create lubricant trial opportunities at the point of contraceptive purchase.

Cupid is an Indian manufacturer with relevance to both consumer and institutional contraceptive and lubricant supply. Its position reflects the importance of domestic manufacturing in price-sensitive and procurement-oriented markets.

Good Clean Love focuses on natural and clinically positioned vaginal-health products. Its September 2024 FDA clearance for Coconut Hybrid provides a regulatory basis for its hybrid-formulation strategy.

LifeStyles Healthcare markets lubricants alongside condom products. Its opportunity rests on cross-category distribution and positioning for consumers seeking condom-compatible, sensitivity-oriented products.

Lovehoney Group operates as a sexual-wellness retailer and brand owner. Its same-day delivery arrangement with Just Eat Takeaway illustrates how specialist retailers are using fulfillment partnerships to defend convenience and broaden access.

Mayer Laboratories markets lubricants under the Kimono brand and can use condom pairings to encourage lubricant trial among consumers who may not otherwise make a separate purchase.

Peptonic Medical is developing an intimate self-care platform around VagiVital. Its Active Glide introduction connects lubrication with menopause-related comfort and fragrance-free formulation priorities.

Reckitt competes through Durex and K-Y. Its clinical study of water-based and silicone-based lubricants for vaginal dryness relief, completed in 2023, indicates continuing investment in evidence that can support therapeutic use positioning. Durex Canada's campaign also shows Reckitt's use of pleasure-oriented communication to widen the addressable consumer base.

SASMAR is associated with fertility-oriented lubricant products, including Conceive Plus. Fertility-safe positioning addresses consumers who may avoid conventional lubricants because of sperm-compatibility concerns.

Sliquid specializes in vegan, body-safe lubricant formulations across water-based, silicone-based, and hybrid formats. Its relevance lies in clean-label positioning for consumers concerned about glycerin, parabens, or unnecessary additives.

The Yes Company focuses on organic and natural lubricant formats, including water- and oil-based options. Its position is strongest among consumers and clinicians seeking natural-formulation alternatives in European markets.

Toaster Labs markets Playground lubricants to younger adult consumers through digitally oriented brand communication and premium water-based product design.

Hello Cake expanded its operating footprint through the acquisition of Trigg Laboratories and the WET brand in October 2024. Vertical integration gives the company manufacturing, distribution, and white-label capabilities that can improve launch speed and supply control.

Uberlube competes with a minimalist silicone-based product built around dimethicone and vitamin E. Its differentiation depends on a focused ingredient proposition and use across intimate and adjacent lifestyle applications.

Competition is therefore moving beyond traditional brand recognition. Incumbents retain an advantage where pharmacy and mass retail dominate, but specialist brands can win in online environments by offering credible formulation distinctions. Acquisition activity suggests that manufacturing capacity and brand ownership are becoming as strategically important as product marketing.

Recent Industry Developments

October 2024 - Hello Cake acquires Trigg Laboratories and closes USD 18 million Series B Hello Cake announced the acquisition of Trigg Laboratories, the manufacturer of the WET brand, alongside an USD 18 million Series B financing round. The transaction included Trigg's 70,000-square-foot manufacturing and distribution facility and added white-label production capabilities to Hello Cake's platform.

September 2024 - Peptonic Medical launches VagiVital Active Glide Peptonic Medical introduced VagiVital Active Glide in Nordic markets as a fragrance-free, water-based lubricant built on its ActiveGel platform. The company subsequently reported early sales momentum and pharmacy e-store availability.

September 2024 - Good Clean Love receives FDA 510(k) clearance for Coconut Hybrid The FDA cleared Good Clean Love's Coconut Hybrid personal lubricant under K242162 on September 19, 2024.